ARIX BIOSCIENCE PLC
ARIX | IL
Overview
Corporate Details
- ISIN(s):
- GB00BD045071
- LEI:
- 213800OVT3AHQCXNIX43
- Country:
- United Kingdom
- Address:
- 1 More London Place, SE1 2AF London
- Website:
- https://arixbioscience.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
ARIX BIOSCIENCE PLC invests in innovative life sciences companies, supporting breakthroughs in biotechnology and healthcare.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2024-02-12 14:02 |
Declaration of Voting Results & Voting Rights Announcements
Arix Bioscience Plc - Results of 2nd General Meeting
|
English | 123.9 KB | |
| 2024-02-12 13:00 |
Declaration of Voting Results & Voting Rights Announcements
Scheme Effective
|
English | 28.0 KB | |
| 2024-02-12 08:00 |
Regulatory News Service
Suspension of Trading in Shares
|
English | 19.2 KB | |
| 2024-02-07 12:30 |
Capital/Financing Update
Transaction Update
|
English | 30.8 KB | |
| 2024-01-29 14:06 |
Declaration of Voting Results & Voting Rights Announcements
Arix Bioscience Plc - Results of 1st General Meeting
|
English | 61.5 KB | |
| 2024-01-29 13:15 |
Declaration of Voting Results & Voting Rights Announcements
Results of First General Meeting
|
English | 28.6 KB | |
| 2024-01-24 18:30 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 66.9 KB | |
| 2024-01-23 11:42 |
General Meeting Notice
Arix Bioscience Plc - Circular and Notice of Second General Meeting
|
English | 138.5 KB | |
| 2024-01-23 08:00 |
General Meeting Notice
Update on the Scheme and Publication of Notice of Second General Meeting
|
English | 39.2 KB | |
| 2024-01-22 08:00 |
Board/Management Change
Update on the Scheme and Resignation of Directors
|
English | 22.4 KB | |
| 2024-01-19 08:01 |
Regulatory News Service
Financial update on Harpoon Therapeutics acquisition by Merck (MSD)
|
English | 11.7 KB | |
| 2024-01-19 08:00 |
Regulatory News Service
Unaudited NAV for December 2023
|
English | 15.1 KB | |
| 2024-01-08 18:15 |
Regulatory News Service
Portfolio company Harpoon Therapeutics to be acquired by Merck (MSD)
|
English | 58.4 KB | |
| 2024-01-05 08:00 |
Prospectus
Publication of Circular and RTW Bio Prospectus
|
English | 43.5 KB | |
| 2024-01-04 18:30 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 66.4 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |